New study tests High-Tech bladder diary for better diagnosis

NCT ID NCT05702294

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether an automated measuring device can improve the accuracy of bladder diaries in women with lower urinary tract symptoms. 187 women recorded their urine volume using both a traditional paper diary and an electronic device. The goal was to see if the device provides more precise data to help doctors diagnose and treat bladder problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

187 people

The number who actually took part.

Started

Sep 2022

Finished

Aug 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Eligibility criteria for females with lower urinary tract symptoms: Inclusion Criteria: * Females * 18 years of age or above * Females presenting with lower urinary tract symptoms Exclusion Criteria: * Females who have a mental/physical disability which would make them unable to understand/comply with the requirements of the study. Eligibility criteria for healthy volunteers: Inclusion criteria * Female * 18 years of age or above Exclusion criteria * Females who have a mental/physical disability which would make them unable to understand/comply with the requirements of the study. * Female with (LUTS).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Lower Urinary Tract Symptoms overactive bladder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Birmingham Women's and Children's Hospital

    Birmingham, B15 2TG, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.